🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
BioMarin Pharmaceutical Inc. (BMRN)
NASDAQ: BMRN · Real-Time Price · USD
60.41
-1.01 (-1.64%)
At close: Nov 20, 2026, 4:00 PM EST
60.41
0.00 (0.00%)
After-hours: Nov 20, 2026, 4:04 PM EST

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
VOXZOGO Revenue
990.81M926.92M735.09M
VIMIZIM Revenue
825.90M792.05M739.78M
NAGLAZYME Revenue
493.37M485.40M479.58M
PALYNZIQ Revenue
461.09M433.31M355.05M
BRINEURA Revenue
200.58M186.40M169.08M
ALDURAZYME Revenue
186.26M208.51M183.89M
KUVAN Revenue
94.61M99.53M120.90M
ROCTAVIAN Revenue
27.84M35.64M26.07M
Total Net Product Revenue
3.62B3.17B2.81B
Royalty and Other Revenue
38.26M53.49M44.47M
Revenue (Other)
-27.84M-35.64M-26.07M
Revenue (Total)
3.66B3.22B2.85B

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Royalty and Other Revenue
38.26M53.49M44.47M
United States Revenue
1.28B1.10B924.81M
Europe Revenue
1.09B874.33M829.03M
Latin America Revenue
455.85M435.48M378.08M
Rest of World Revenue
604.74M544.47M493.63M
Revenue (Other)
186.26M208.51M183.89M
Revenue (Total)
3.66B3.22B2.85B